Reald Spark, LLC v. Microsoft Corporation

CourtDistrict Court, W.D. Washington
DecidedJanuary 30, 2024
Docket2:22-cv-00942
StatusUnknown

This text of Reald Spark, LLC v. Microsoft Corporation (Reald Spark, LLC v. Microsoft Corporation) is published on Counsel Stack Legal Research, covering District Court, W.D. Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Reald Spark, LLC v. Microsoft Corporation, (W.D. Wash. 2024).

Opinion

1 2 3 4

5 6 7 8 UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON 9 AT SEATTLE 10 11 REALD SPARK, LLC, CASE NO. 2:22-cv-00942-TL 12 Plaintiff, ORDER ON MOTIONS TO STAY v. AND DISMISS CLAIMS 13 MICROSOFT CORPORATION, 14 Defendant. 15

16 17 This matter is before the Court on Defendant Microsoft Corporation’s Renewed Motion 18 to Stay After Institution of Inter Partes Review (Dkt. No. 121) and Plaintiff RealD Spark’s 19 Motion to Voluntarily Dismiss the ‘985 Patent Claims Without Prejudice Pursuant to Federal 20 Rule of Civil Procedure 41(a)(2) (Dkt. No. 125). Having reviewed the Parties’ briefing and the 21 relevant record, and finding oral argument unnecessary, see LCR 7(b)(4), the Court GRANTS 22 Defendant’s motion to stay, and GRANTS Plaintiff’s motion to dismiss the ‘985 Patent claims. 23 The Court assumes familiarity with the facts of the case. Relevant to the instant motions, 24 on August 25, 2023, the Court denied a motion by Defendant to stay the matter pending inter 1 partes review (“IPR”) of the ‘985 Patent. Dkt. No. 86. The Court noted that “[i]f the PTAB 2 [Patent Trial and Appeal Board] grants review, then Defendant may refile its request for a stay at 3 that time.” Id. at 3. On December 21, 2023, the PTAB instituted IPR. Dkt. No. 119-1 (PTAB 4 decision). Defendants now renew their motion to stay the matter. Dkt. No. 121; see also Dkt.

5 Nos. 127 (response), 131 (reply). Plaintiff also moves to dismiss its patent infringement claims. 6 Dkt. No. 125; see also Dkt. Nos. 131 (response), 133 (reply). 7 As an initial matter, Defendant “does not oppose” Plaintiff’s motion to dismiss its patent 8 infringement claims. Dkt. No. 131 at 2; see id. at 3–4. Therefore, Plaintiff’s motion is GRANTED, 9 and the patent claims are DISMISSED without prejudice. However, the Parties dispute whether a 10 stay is appropriate. 11 “The [district] court has the authority to stay [a] case pending the outcome of an IPR 12 petition.” WAG Acquisition, LLC v. Amazon.com, Inc., No. C22-1424, 2023 WL 1991888, at *1 13 (W.D. Wash. Feb. 14, 2023). “To determine whether to grant such a stay, the court considers 14 (1) whether a stay will simplify the court proceedings; (2) the stage of the case; and (3) whether a

15 stay will unduly prejudice or present a clear tactical disadvantage to the non-moving party.” Id. 16 (citing Pac. Bioscience Lab’ys, Inc. v. Pretika Corp., 760 F. Supp. 2d 1061, 1063 (W.D. Wash. 17 2011); accord WSOU Invs., LLC v. F5 Networks, Inc., No. C20-1878 et al., 2022 WL 766997, at 18 *1 (W.D. Wash. Mar. 14, 2022) (citing the same). Here, the factors weigh in favor of a stay. 19 First, as to simplification of the case, the Court notes that Plaintiff seeks dismissal of its 20 patent claims without prejudice while expressly reserving its right to bring the same claims again 21 later. See Dkt. No. 125 at 10 (“[Dismissal without prejudice] would also permit [Plaintiff] to 22 refile a lawsuit alleging infringement of the ‘985 Patent after the Patent Office confirms whether 23 the claims of the ‘985 Patent are valid—which [Plaintiff] has every confidence it will.”). Thus,

24 dismissal of Plaintiff’s patent claims does not moot Defendant’s patent counterclaims. Plaintiff 1 asserts that Defendant’s refusal to dismiss its counterclaims is “nothing more than a blatant 2 attempt to manufacture a reason to stay the entire case.” Dkt. No. 127 at 5. But the Court notes 3 that Defendant raised patent counterclaims in its first Answer on December 9, 2022—long before 4 its IPR petition was filed in June 2023. See Dkt. No. 30 at 47–49; see also Dkt. No. 64-4

5 (petition). Plaintiff also made a choice to file a lawsuit that included patent claims which drew 6 counterclaims that remain live. The Court believes it would benefit from the expert analysis of 7 the PTAB with regard to the counterclaims. Moreover, Plaintiff’s patent claims are factually 8 related to its non-patent claims for breach of contract and trade secret misappropriation, as well 9 as Defendant’s counterclaims, as they involve some (though not total) overlap of facts and 10 witnesses, including the named patent inventors. See Dkt. No. 121 at 15–16. Plaintiff’s dismissal 11 without prejudice of its patent claims does not eliminate the risk of the Court and the Parties 12 expending resources on multiple trials for related claims. Therefore, the simplification factor 13 weighs in favor of a stay. 14 The remaining factors also weigh in favor of a stay. As to the stage of the case, Plaintiff

15 argues both that “much of the work is yet to be done” (Dkt. No. 125 at 2) and that “[t]he case has 16 moved well beyond the initial phases and is rapidly approaching trial readiness” (Dkt. No. 127 at 17 13). Plaintiff cannot have it both ways. At any rate, claim construction has not yet occurred, and 18 trial is still over nine months away. See Dkt. No. 91. As to undue prejudice or clear tactical 19 disadvantage, Plaintiff’s assertions are conclusory, unsupported, or little beyond the prejudice 20 inherent in a stay. Depositions of fact witnesses will be completed by February 9, 2024, 21 mitigating concern about the loss of witness testimony over time.1 See Dkt. No. 127 at 1; Dkt. 22

1 Defendant also appears to want it both ways: it argues both that “the case is still in the relatively early stages where 23 most fact depositions have not taken place” (Dkt. No. 121 at 13) and that “the parties are in the process of completing all fact witness depositions, with five having occurred already and the remainder scheduled to be 24 completed by February 9” (Dkt. No. 131 at 5–6). 1 No. 131 at 5–6. Moreover, Defendant states (and Plaintiff does not dispute) that “[Plaintiff] 2 ceased doing business in eye-gaze correction and terminated its employees in this area years 3 ago.” Dkt. No. 121 at 14. Plaintiff’s only evidence of harm is a statement from its CEO that a 4 stay would harm Plaintiff’s ability to raise capital and hire employees (Dkt. No. 65-11 ¶ 3), but

5 Plaintiff provides no other evidence or examples that support this assertion. 6 Accordingly, it is hereby ORDERED: 7 (1) Defendant’s Renewed Motion to Stay After Institution of Inter Partes Review 8 (Dkt. No. 121) is GRANTED. This matter is STAYED until the PTAB issues a 9 decision on Defendant’s IPR petition, except that any fact depositions that the 10 Parties have agreed to complete before February 9, 2024, may proceed. 11 (2) Plaintiff’s Motion to Voluntarily Dismiss the ‘985 Patent Claims Without 12 Prejudice Pursuant to Federal Rule of Civil Procedure 41(a)(2) (Dkt. No. 125) is 13 GRANTED. Plaintiff’s patent claims are DISMISSED without prejudice. 14 (3) All remaining case deadlines, including the trial date, are VACATED.

15 (4) The Parties SHALL file a joint status report within fourteen (14) days of a 16 decision by the PTAB, including the status of any appeal. 17 Dated this 30th day of January 2024. 18 A 19 Tana Lin United States District Judge 20

21 22 23 24

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pacific Bioscience Laboratories, Inc. v. Pretika Corp.
760 F. Supp. 2d 1061 (W.D. Washington, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
Reald Spark, LLC v. Microsoft Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/reald-spark-llc-v-microsoft-corporation-wawd-2024.